Rapamycin-induced G1 cell cycle arrest employs both TGF-β and Rb pathways.

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Cancer Letters

• Publication date

  2015-05-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.canlet.2015.01.043PMID 25659819PMCID PMC4415112
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Cyclin D activates the Rb tumor suppressor by mono-phosphorylation

  2014influential reference
• Inhibition of S6 kinase suppresses the apoptotic effect of eIF4E ablation by inducing TGF-β-dependent G1 cell cycle arrest.

  2013cited by this paper
• Suppression of AKT Phosphorylation Restores Rapamycin-Based Synthetic Lethality in SMAD4-Defective Pancreatic Cancer Cells

  2013cited by this paper
• Amino Acids and mTOR Mediate Distinct Metabolic Checkpoints in Mammalian G1 Cell Cycle

  2013cited by this paper
• Metabolic reprogramming: a cancer hallmark even warburg did not anticipate.

  2012cited by this paper
• Molecular damage in cancer: an argument for mTOR-driven aging

  2011cited by this paper
• High-dose rapamycin induces apoptosis in human cancer cells by dissociating mTOR complex 1 and suppressing phosphorylation of 4E-BP1

  2011cited by this paper
• Activating mutations of TOR (target of rapamycin)

  2011cited by this paper
• Regulation of G1 Cell Cycle Progression: Distinguishing the Restriction Point from a Nutrient-Sensing Cell Growth Checkpoint(s).

  2010cited by this paper
• Not all substrates are treated equally: Implications for mTOR, rapamycin-resistance, and cancer therapy

  2009cited by this paper
• Regulation of cyclin D1 expression by mTORC1 signaling requires eukaryotic initiation factor 4E-binding protein 1

  2008influential reference
• Rapamycin differentially inhibits S6Ks and 4E-BP1 to mediate cell-type-specific repression of mRNA translation

  2008cited by this paper
• Defective TGF-beta signaling sensitizes human cancer cells to rapamycin.

  2008cited by this paper
• Defective TGF-β signaling sensitizes human cancer cells to rapamycin

  2008cited by this paper
• TGFbeta in Cancer.

  2008cited by this paper
• Regulation of mTORC1 and mTORC2 Complex Assembly by Phosphatidic Acid: Competition with Rapamycin

  2008cited by this paper
• eIF4E, the mRNA cap-binding protein: from basic discovery to translational research.

  2008cited by this paper
• Suppression of TGF-beta signaling by phospholipase D.

  2007cited by this paper
• Suppression TGF-β Signaling by Phospholipase D

  2007cited by this paper
• Determinants of Rapamycin Sensitivity in Breast Cancer Cells

  2004cited by this paper
• mTOR Controls Cell Cycle Progression through Its Cell Growth Effectors S6K1 and 4E-BP1/Eukaryotic Translation Initiation Factor 4E

  2004cited by this paper
• Expression of constitutively active 4EBP-1 enhances p27Kip1 expression and inhibits proliferation of MCF7 breast cancer cells

  2003cited by this paper
• Phospholipase D confers rapamycin resistance in human breast cancer cells

  2003cited by this paper
• SB-431542 is a potent and specific inhibitor of transforming growth factor-beta superfamily type I activin receptor-like kinase (ALK) receptors ALK4, ALK5, and ALK7.

  2002cited by this paper
• Rapamycin Potentiates Transforming Growth Factor β-Induced Growth Arrest in Nontransformed, Oncogene-Transformed, and Human Cancer Cells

  2002cited by this paper
• Regulation of G(1) cell-cycle progression by oncogenes and tumor suppressor genes.

  2002influential reference
• Regulation of G1 cell-cycle progression by oncogenes and tumor suppressor genes

  2002cited by this paper
• Phosphatidic Acid-Mediated Mitogenic Activation of mTOR Signaling

  2001cited by this paper
• CDK inhibitors: positive and negative regulators of G1-phase progression.

  1999cited by this paper
• Cyclin D Expression Is Controlled Post-transcriptionally via a Phosphatidylinositol 3-Kinase/Akt-dependent Pathway*

  1998cited by this paper
• TβRI Phosphorylation of Smad2 on Ser465 and Ser467 Is Required for Smad2-Smad4 Complex Formation and Signaling*

  1997cited by this paper
• TGF-beta mediated G1 arrest in a human melanoma cell line lacking p15INK4B: evidence for cooperation between p21Cip1/WAF1 and p27Kip1.

  1996cited by this paper

• Leveraging HIV-Specific CAR T Cells and Rapamycin Treatment in “Kick-and-Kill” HIV Cure Approaches

  2026cites this paper
• mTORC1 regulates the proliferation of SOX9+ porcine skin-derived stem cells (pSDSCs) by promoting S6K phosphorylation

  2025cites this paper
• Divergence between neural and retinal lineage specification during human brain development by signal Transduction.

  2025cites this paper
• Cell Painting in HepaRG Cells: An Interlaboratory Reproducibility Study.

  2025cites this paper
• Exosomal delivery of rapamycin modulates blood-brain barrier penetration and VEGF axis in glioblastoma.

  2025cites this paper
• Crosstalk between m6A modification and autophagy in cancer

  2024cites this paper
• Regulatory role of the mTOR signaling pathway in autophagy and mesangial proliferation in IgA nephropathy

  2024cites this paper
• Prim-O-glucosylcimifugin alleviates influenza virus-induced pneumonia in mice by inhibiting the TGF-β1/PI3KCD/MSK2/RELA signalling pathway

  2024cites this paper
• Osmotic Stress Influences Microtubule Drug Response Via WNK1 Kinase Signaling

  2024cites this paper
• Stigmasterol Exerts an Anti-Melanoma Property through Down-Regulation of Reactive Oxygen Species and Programmed Cell Death Ligand 1 in Melanoma Cells

  2024cites this paper
• Current State and Future Challenges for PI3K Inhibitors in Cancer Therapy

  2023cites this paper
• Effect of miRNA-99a along with TGF-?1(C/G +915) in female with secondary unexplained infertility

  2023cites this paper
• An SS31-rapamycin conjugate via RBC hitchhiking for reversing acute kidney injury.

  2023cites this paper
• Effect of rapamycin on Cryptococcus neoformans: cellular organization, biophysics and virulence factors.

  2023cites this paper
• Molecular and therapeutic insights of rapamycin: a multi-faceted drug from Streptomyces hygroscopicus

  2023cites this paper
• Theabrownins Produced via Chemical Oxidation of Tea Polyphenols Inhibit Human Lung Cancer Cells in vivo and in vitro by Suppressing the PI3K/AKT/mTOR Pathway Activation and Promoting Autophagy

  2022cites this paper
• New Visions on Natural Products and Cancer Therapy: Autophagy and Related Regulatory Pathways

  2022cites this paper
• Tumor microenvironment in non-melanoma skin cancer resistance to photodynamic therapy

  2022cites this paper
• PLA-PEG Implant as a Drug Delivery System in Glaucoma Surgery: Experimental Study

  2022cites this paper
• Rapamycin induces autophagy and apoptosis in Kaposiform hemangioendothelioma primary cells in vitro.

  2022cites this paper
• Gleevec and Rapamycin Synergistically Reduce Cell Viability and Inhibit Proliferation and Angiogenic Function of Mouse Bone Marrow-Derived Endothelial Progenitor Cells

  2021cites this paper
• Optimization of BCG Therapy Targeting Neutrophil Extracellular Traps, Autophagy, and miRNAs in Bladder Cancer: Implications for Personalized Medicine

  2021cites this paper
• Cancer cells with defective RB and CDKN2A are resistant to the apoptotic effects of rapamycin.

  2021cites this paper
• Repression of Smad4 by MicroRNA-1285 moderates TGF-β-induced epithelial–mesenchymal transition in proliferative vitreoretinopathy

  2021cites this paper
• Metformin impairs cisplatin resistance effects in A549 lung cancer cells through mTOR signaling and other metabolic pathways

  2021cites this paper
• SIRT2 Affects Primary Cilia Formation by Regulating mTOR Signaling in Retinal Pigmented Epithelial Cells

  2020cites this paper
• Reactive oxygen species-mediated cellular genotoxic stress is involved in 1-nitropyrene-induced trophoblast cycle arrest and fetal growth restriction.

  2020cites this paper
• Analysis of mTOR pathway expression in lymphatic malformation and related diseases

  2020cites this paper
• Infrared‐A Irradiation‐induced Inhibition of Human Keratinocyte Proliferation and Potential Mechanisms

  2020cites this paper
• Albumin promotes the progression of fibroblasts through late G1 into S-phase in the absence of growth factors

  2020cites this paper
• The Use of Geroprotective Agents (mTOR Inhibitors) in the Treatment of Cancer Patients

  2020cites this paper
• The crosstalk between platelets and body fat: A reverse translational study.

  2020cites this paper
• Autophagy in tumor and tumor microenvironment

  2020cites this paper
• Cellular and molecular mechanisms of xenobiotics-induced premature senescence.

  2020cites this paper
• Effect of Rapamycin on Canine Mast Cell Cancer Cells Following Radiation

  2020cites this paper
• The Autophagy Conundrum in Cancer Development, Progression and Therapeutics

  2020cites this paper
• THE EARLY CELLULAR REACTION OF EYE TISSUES TO THE IMPLANTATION OF BIORESORBABLE DRAINAGES SATURATED BY IMMUNOSUPPRESSANTS WITH A SELECTIVE MECHANISM OF ACTION

  2020cites this paper
• The mTOR Pathway in Reproduction: From Gonadal Function to Developmental Coordination.

  2019cites this paper
• G9a promotes cell proliferation and suppresses autophagy in gastric cancer by directly activating mTOR

  2019cites this paper
• Inhibition of the mTOR pathway: A new mechanism of β cell toxicity induced by tacrolimus

  2019cites this paper
• Glutamine as an Essential Amino Acid for KRas-Driven Cancer Cells.

  2019cites this paper
• Estrogen Receptor Beta (ERβ) Mediated-CyclinD1 Degradation via Autophagy Plays an Anti-Proliferation Role in Colon Cells

  2019cites this paper
• The Effect of LKB1 Activity on the Sensitivity to PI3K/mTOR Inhibition in Non-Small Cell Lung Cancer.

  2019cites this paper
• Metabolic Imaging Reveals a Unique Preference of Symmetric Cell Division and Homing of Leukemia-Initiating Cells in an Endosteal Niche.

  2019cites this paper
• Roles of TGFβ1 in the expression of phosphoinositide 3-kinase isoform genes and sensitivity and response of lung telocytes to PI3K inhibitors

  2019cites this paper
• Leucine reduces the proliferation of MC3T3-E1 cells through DNA damage and cell senescence.

  2018cites this paper
• Rapamycin, proliferation and geroconversion to senescence

  2018cites this paper
• Autophagy alteration prevents primary cilium disassembly in RPE1 cells.

  2018cites this paper
• Dual role of autophagy in hallmarks of cancer

  2018cites this paper
• Mechanisms for Survival and Drug Resistance in Cancer Cells

  2018cites this paper
• Rapamycin enhances the antiproliferative effect of transforming growth factor-β on MCF-7 human breast cancer cells.

  2017cites this paper
• Lipid Sensing by Mammalian Target of Rapamycin

  2017cites this paper
• Emerging roles of hnRNPA1 in modulating malignant transformation

  2017cites this paper
• Lipid sensing by mTOR complexes via de novo synthesis of phosphatidic acid

  2017cites this paper
• Blocking Smad2 signalling with loganin attenuates SW10 cell cycle arrest induced by TNF-α

  2017cites this paper
• PEGylated lipid bilayer-wrapped nano-graphene oxides for synergistic co-delivery of doxorubicin and rapamycin to prevent drug resistance in cancers

  2017cites this paper
• The Enigma of Rapamycin Dosage

  2016cites this paper
• The therapeutic potential of mTOR inhibitors in breast cancer.

  2016cites this paper
• Inhibition of mTOR enhances radiosensitivity of lung cancer cells and protects normal lung cells against radiation.

  2016cites this paper
• The HDM2 (MDM2) Inhibitor NVP-CGM097 Inhibits Tumor Cell Proliferation and Shows Additive Effects with 5-Fluorouracil on the p53-p21-Rb-E2F1 Cascade in the p53wild type Neuroendocrine Tumor Cell Line GOT1

  2016cites this paper
• RAPAMYCIN INCREASES LENGTH AND MECHANOSENSORY FUNCTION OF PRIMARY CILIA IN RENAL EPITHELIAL AND VASCULAR ENDOTHELIAL CELLS

  2016cites this paper
• A Late G1 Lipid Checkpoint That Is Dysregulated in Clear Cell Renal Carcinoma Cells*

  2016cites this paper
• Cell cycle status dictates effectiveness of rapamycin

  2015cites this paper
• Apoptotic effects of high-dose rapamycin occur in S-phase of the cell cycle

  2015cites this paper
• Rapamycin Protects from Type-I Peritoneal Membrane Failure Inhibiting the Angiogenesis, Lymphangiogenesis, and Endo-MT

  2015cites this paper
• Molecular Pathways: Increased Susceptibility to Infection Is a Complication of mTOR Inhibitor Use in Cancer Therapy

  2015cites this paper
• Therapeutic ultrasound stimulates MC3T3‐E1 cell proliferation through the activation of NF‐κB1, p38α, and mTOR

  2015cites this paper